Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on May 21, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Developmental Neurotoxicity Testing Protocol Design

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541620
New
Federal
B--ONYX RANCH SVRA PROJECT
Solicitation # 140G0326Q0218
Solicitation 140G0326Q0218 is a request for quotation from the Department of the Interior for advanced statistical modeling and assistance for the Onyx Ranch State Vehicle Recreation Area. The project requires a contractor to analyze a 289-hectare dataset to identify critical issues and map occurrences of invasive species, fire-prone grasses, and protected species, including the desert tortoise and western Joshua trees. Key deliverables include publication-quality figures, distribution maps, and statistical models developed using ArcGIS and various advanced methodologies such as general linear mixed effects models and k-means clustering. The estimated period of performance is from October 1, 2026, to February 28, 2027, with work performed at the vendor's facility. The award will be based on a tradeoff method, requiring contractors to demonstrate advanced statistical expertise through peer-reviewed publications from the last 15 years and proficiency in complex spatial and non-parametric analysis. Required submission documents include a signed SF 18 form, a firm fixed-price quote, a technical submission detailing qualifications, a list of prior relevant contracts with references, and a SAM UEI. Initial drafts of specific tasks are due within 60 days of award, with model drafts due within 90 days. All deliverables become government property, and invoicing must be submitted based on hourly rates and hours worked. Responses are due to the contracting officer by September 17, 2026, at 1500 PST.
Office Of Acquisiton Grants

POSTED

about 15 hours ago

DEADLINE

in 6 days

AI Contract Overview

Show more

This contract involves developing standardized in vitro protocols aimed at assessing the developmental neurotoxicity potential of foods and dietary supplements using a three-dimensional blood-brain barrier (3D BBB) model. The work includes designing exposure regimens and selecting appropriate biomarkers to ensure reliable and reproducible testing methods. The project is intended to support regulatory evaluation by offering validated approaches to detect neurotoxic effects during development. The contract is a subcontract issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, with the place of performance located in Silver Spring. It falls under the NAICS code 541620, which pertains to environmental consulting services, reflecting the scientific and technical nature of the work. Responses to the solicitation were due by June 12, 2026, following its posting on May 21, 2026. This initiative is part of broader efforts to enhance safety assessment protocols for consumer health products.

General Info

Develop standardized in vitro protocols using 3D BBB model to assess dietary neurotoxicity.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

541620 - Environmental Consulting ServicesView NAICS

Place of Performance

Silver Spring, MD, USA

Set-Aside

NONE

Documents

This scope was carved out of FDA_5212026.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Development of 3D Human Blood Brain Barrier Formation Assay

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Develop standardized in vitro protocols to assess developmental neurotoxicity of foods and dietary supplements using the 3D BBB model, including exposure regimens and biomarker selection.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS